Patents Assigned to Berlin Cures GmbH
  • Aptamers for use in inhibition and/or suppression of TLR9 activation
    Patent number: 10947545
    Abstract: The present invention relates to new aptamer molecules for use in therapy of a subject by inhibiting or suppressing the activation of TLR9 in a cell, a method of inhibiting or suppressing the activation of TLR9 in a cell using such aptamer molecules, a pharmaceutical composition and a kit comprising such aptamer molecules and the use of aptamer molecules for inhibiting or suppressing TLR9 activation.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: March 16, 2021
    Assignee: Berlin Cures GmbH
    Inventors: Annekathrin Haberland, Katrin Wenzel